These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 29928988

  • 41. Review of embryo-fetal developmental toxicity studies performed for recent FDA-approved pharmaceuticals.
    Ishihara-Hattori K, Barrow P.
    Reprod Toxicol; 2016 Sep; 64():98-104. PubMed ID: 27112525
    [Abstract] [Full Text] [Related]

  • 42. Effects of melamine on pregnant dams and embryo-fetal development in rats.
    Kim SH, Lee IC, Lim JH, Shin IS, Moon C, Kim SH, Park SC, Kim HC, Kim JC.
    J Appl Toxicol; 2011 Aug; 31(6):506-14. PubMed ID: 21706515
    [Abstract] [Full Text] [Related]

  • 43. Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation.
    Moffat GJ, Retter MW, Kwon G, Loomis M, Hock MB, Hall C, Bussiere J, Lewis EM, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):178-88. PubMed ID: 24753333
    [Abstract] [Full Text] [Related]

  • 44. Embryotoxicity studies of norfloxacin in cynomolgus monkeys: I. Teratology studies and norfloxacin plasma concentration in pregnant and nonpregnant monkeys.
    Cukierski MA, Prahalada S, Zacchei AG, Peter CP, Rodgers JD, Hess DL, Cukierski MJ, Tarantal AF, Nyland T, Robertson RT.
    Teratology; 1989 Jan; 39(1):39-52. PubMed ID: 2718139
    [Abstract] [Full Text] [Related]

  • 45. Effects of tert-butyl acetate on maternal toxicity and embryo-fetal development in Sprague-Dawley rats.
    Yang YS, Ahn TH, Lee JC, Moon CJ, Kim SH, Park SC, Chung YH, Kim HY, Kim JC.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Oct; 80(5):374-82. PubMed ID: 17948321
    [Abstract] [Full Text] [Related]

  • 46. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H.
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [Abstract] [Full Text] [Related]

  • 47. Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment.
    Destexhe E, Stannard D, Wilby OK, Grosdidier E, Baudson N, Forster R, Gérard CM, Garçon N, Segal L.
    Reprod Toxicol; 2015 Jan; 51():90-105. PubMed ID: 25530039
    [Abstract] [Full Text] [Related]

  • 48. Repeated administration of diphenyl diselenide to pregnant rats induces adverse effects on embryonic/fetal development.
    Weis SN, Favero AM, Stangherlin EC, Manarin FG, Rocha JB, Nogueira CW, Zeni G.
    Reprod Toxicol; 2007 Feb; 23(2):175-81. PubMed ID: 17095185
    [Abstract] [Full Text] [Related]

  • 49. FCGR2A and FCGR3A Genotypes Correlate with Farletuzumab Response in Patients with First-Relapsed Ovarian Cancer Exhibiting Low CA125.
    Wang W, Somers EB, Ross EN, Kline JB, O'Shannessy DJ, Schweizer C, Weil S, Grasso L, Nicolaides NC.
    Cytogenet Genome Res; 2017 Feb; 152(4):169-179. PubMed ID: 29041009
    [Abstract] [Full Text] [Related]

  • 50. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis).
    Hendrickx AG, Hummler H.
    Teratology; 1992 Jan; 45(1):65-74. PubMed ID: 1731397
    [Abstract] [Full Text] [Related]

  • 51. A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse.
    Vergote I, Armstrong D, Scambia G, Teneriello M, Sehouli J, Schweizer C, Weil SC, Bamias A, Fujiwara K, Ochiai K, Poole C, Gorbunova V, Wang W, O'Shannessy D, Herzog TJ.
    J Clin Oncol; 2016 Jul 01; 34(19):2271-8. PubMed ID: 27001568
    [Abstract] [Full Text] [Related]

  • 52. Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring.
    Nicholson SM, Carlesso G, Cheng LI, Cook H, DaCosta K, Leininger J, McKeever K, Scott SW, Taylor D, Streicher K, Eck S, Reed M, Faggioni R, Herbst R, Dixit R, Ryan PC.
    Reprod Toxicol; 2017 Dec 01; 74():116-133. PubMed ID: 28916434
    [Abstract] [Full Text] [Related]

  • 53. Embryo-fetal development toxicity of prenatal exposure to penequine hydrochloride intramuscularly in rats.
    Zhang Z, Zhang Q, Wang Z, Wei J, Wang A.
    Food Chem Toxicol; 2007 Apr 01; 45(4):592-9. PubMed ID: 17134811
    [Abstract] [Full Text] [Related]

  • 54. Prenatal developmental toxicity of decabromodiphenyl ethane in the rat and rabbit.
    Hardy ML, Mercieca MD, Rodwell DE, Stedeford T.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Apr 01; 89(2):139-46. PubMed ID: 20437473
    [Abstract] [Full Text] [Related]

  • 55. Intravitreal RTH258 (brolucizumab) demonstrates no effect on pregnancy, parturition, embryofetal or postnatal development in cynomolgus monkeys.
    Booler H, DeLise AM, Nimz E, Shefchek D, Luetjens CM.
    Reprod Toxicol; 2023 Oct 01; 121():108468. PubMed ID: 37666285
    [Abstract] [Full Text] [Related]

  • 56. Morphologic, stereologic, and morphometric evaluation of the nervous system in young cynomolgus monkeys (Macaca fascicularis) following maternal administration of tanezumab, a monoclonal antibody to nerve growth factor.
    Butt M, Evans M, Bowman CJ, Cummings T, Oneda S, Shelton D, Zorbas M.
    Toxicol Sci; 2014 Dec 01; 142(2):463-76. PubMed ID: 25326242
    [Abstract] [Full Text] [Related]

  • 57. Effects of zearalenone on in utero development in rats.
    Collins TF, Sprando RL, Black TN, Olejnik N, Eppley RM, Alam HZ, Rorie J, Ruggles DI.
    Food Chem Toxicol; 2006 Sep 01; 44(9):1455-65. PubMed ID: 16797818
    [Abstract] [Full Text] [Related]

  • 58. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Osterburg I, Fuchs A, Buse E, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr 01; 86(2):144-56. PubMed ID: 19283860
    [Abstract] [Full Text] [Related]

  • 59. Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.
    Vergote IB, Marth C, Coleman RL.
    Cancer Metastasis Rev; 2015 Mar 01; 34(1):41-52. PubMed ID: 25564455
    [Abstract] [Full Text] [Related]

  • 60. Evaluation of bendectin embryotoxicity in nonhuman primates: II. Double-blind study in term cynomolgus monkeys.
    Hendrickx AG, Cukierski M, Prahalada S, Janos G, Booher S, Nyland T.
    Teratology; 1985 Oct 01; 32(2):191-4. PubMed ID: 4049276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.